☆ 4.7 Letter

Is Telomeropathy the Explanation for Combined Pulmonary Fibrosis and Emphysema Syndrome?: Report of a Family with TERT Mutation

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

期刊

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

卷 189, 期 6, 页码 753-754

出版社

AMER THORACIC SOC

DOI: 10.1164/rccm.201309-1724LE

关键词

-

类别

Critical Care Medicine Respiratory System

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Cell Biology

Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally

Marija Gredic, Srikanth Karnati, Clemens Ruppert, Andreas Guenther, Sergey N. Avdeev, Djuro Kosanovic

Summary: Combined pulmonary fibrosis and emphysema (CPFE) is a recently recognized syndrome characterized by the coexistence of interstitial lung fibrosis and emphysema. It predominantly affects males with a history of heavy smoking and presents with dyspnea, preserved lung volumes, and impaired gas exchange capacity. CPFE has a high mortality rate and currently lacks specific treatment options. Further research is needed to understand its clinical manifestations, pathophysiology, and potential etiological factors.

CELLS (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition

Diana Calaras, Alexander G. Mathioudakis, Zsofia Lazar, Alexandru Corlateanu

Summary: Combined pulmonary fibrosis and emphysema (CPFE) is a clinical syndrome characterized by upper lobe emphysema and lower lobe fibrosis, resulting in exercise hypoxemia, normal lung volumes, and reduced diffusion capacity of carbon monoxide. It is more prevalent in males worldwide, with a common risk factor being a smoking history of over 40 pack-years. The distinctive imaging features of CPFE aid in timely detection of common complications such as pulmonary hypertension and lung cancer. High-resolution computed tomography (HRCT) is important for diagnosis and prognosis, and lung cancer independently affects the prognosis of CPFE patients. Treatment options for CPFE are limited, but smoking cessation, usual treatments for pulmonary fibrosis and emphysema, and avoidance of environmental exposures are recommended.

BIOMEDICINES (2023)

添加到收藏夹

Article Critical Care Medicine

Syndrome of Combined Pulmonary Fibrosis and Emphysema An Official ATS/ERS/JRS/ALAT Research Statement

Vincent Cottin, Moises Selman, Yoshikazu Inoue, Alyson W. Wong, Tamera J. Corte, Kevin R. Flaherty, MeiLan K. Han, Joseph Jacob, Kerri A. Johannson, Masanori Kitaichi, Joyce S. Lee, Alvar Agusti, Katerina M. Antoniou, Pauline Bianchi, Fabian Caro, Matias Florenzano, Liam Galvin, Tae Iwasawa, Fernando J. Martinez, Rebecca L. Morgan, Jeffrey L. Myers, Andrew G. Nicholson, Mariaelena Occhipinti, Venerino Poletti, Margaret L. Salisbury, Don D. Sin, Nicola Sverzellati, Thomy Tonia, Claudia Valenzuela, Christopher J. Ryerson, Athol U. Wells

Summary: This research summarizes the definition, characteristics, pathophysiology, and research priorities of combined pulmonary fibrosis and emphysema (CPFE). The research proposes CPFE to be recognized as a syndrome and offers classification criteria and descriptions of radiologic and pathological patterns.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)

Xiaoyi Feng, Yishan Duan, Xiafei Lv, Qinxue Li, Binmiao Liang, Xuemei Ou

Summary: The presence of lung cancer does not significantly increase the risk of acute exacerbation (AE) as a natural course of combined pulmonary fibrosis and emphysema (CPFE). However, CPFE patients with lung cancer tend to be elderly male smokers and have higher levels of inflammatory markers. Pack-years, family history of cancer, fibrinogen levels, and serum C3 levels are independently associated with the presence of lung cancer in CPFE patients. Clinicians should closely monitor CPFE patients, especially those with severe fibrosis and systemic inflammation, for the development of AE.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Critical Care Medicine

Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation

Tsuyoshi Takahashi, Yuriko Terada, Michael K. Pasque, Jingxia Liu, Derek E. Byers, Chad A. Witt, Ruben G. Nava, Varun Puri, Benjamin D. Kozower, Bryan F. Meyers, Daniel Kreisel, G. Alexander Patterson, Ramsey R. Hachem

Summary: CPFE, a characteristic syndrome of smoking-related interstitial lung disease, is associated with higher risks of primary graft dysfunction, acute cellular rejection, and chronic lung allograft dysfunction after lung transplantation. However, the survival rate after transplantation is not significantly different between CPFE and IPF patients.

CHEST (2021)

添加到收藏夹

Editorial Material Critical Care Medicine

Persistent Dyspnea in a 74-Year-Old Man With Normal Spirometry and Lung Volumes

Woon H. Chong, Biplab Saha, Boris Shkolnik

Summary: A 74-year-old man presented with a 1-year history of nonproductive cough and progressive exertional dyspnea. Initial evaluation by primary care physician ruled out obstructive or restrictive lung disease, with no improvement after empiric treatment for COPD exacerbation. Referral to pulmonologist for further evaluation was done due to lack of clinical improvement.

CHEST (2021)

添加到收藏夹

Article Medicine, General & Internal

Differential Genomic Profile in TERT, DSP, and FAM13A Between COPD Patients With Emphysema, IPF, and CPFE Syndrome

Javier Guzman-Vargas, Enrique Ambrocio-Ortiz, Gloria Perez-Rubio, Marco Antonio Ponce-Gallegos, Rafael de Jesus Hernandez-Zenteno, Mayra Mejia, Alejandra Ramirez-Venegas, Ivette Buendia-Roldan, Ramces Falfan-Valencia

Summary: This study identified differential genetic variants between COPD, IPF, and CPFE, with specific genotypes associated with disease risks in IPF and CPFE patients. There are also common genetic variants shared among different diseases.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules

Alan A. Peters, Oliver Weinheimer, Oyunbileg von Stackelberg, Jonas Kroschke, Lars Piskorski, Manuel Debic, Kai Schlamp, Linn Welzel, Moritz Pohl, Andreas Christe, Lukas Ebner, Hans-Ulrich Kauczor, Claus Peter Heussel, Mark O. Wielpuetz

Summary: Quantitative computed tomography (QCT) of the whole lung and nodule-bearing lobe can be valuable in assessing the malignancy risk of pulmonary nodules. The study shows that nodules in subjects with higher emphysema levels and less fibrosis in the lungs are more likely to be malignant.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Small airway dysfunction in idiopathic pulmonary fibrosis

Chengsheng Yin, Huikang Xie, Xian He, Yuan Zhang, Aihong Zhang, Huiping Li

Summary: This study aimed to investigate the occurrence of small airway dysfunction (SAD) comorbidity in idiopathic pulmonary fibrosis (IPF) and its impact on survival. The study found that 34.57% of IPF patients were diagnosed with SAD, and comorbid SAD was an independent risk factor for mortality in IPF patients.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Hematology

IL11 (Interleukin-11) Causes Emphysematous Lung Disease in a Mouse Model of Marfan Syndrome

Benjamin Ng, Chen Xie, Liping Su, Fathima F. Kuthubudeen, Xiu-Yi Kwek, Daryl Yeong, Chee Jian Pua, Stuart A. Cook, Wei-Wen Lim

Summary: Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the FBN1 gene. IL11 plays a role in causing lung disease in a mouse model of MFS. Inhibition of IL11 signaling can reduce lung emphysema, fibrosis, and inflammation in MFS mice, suggesting that targeting IL11 signaling could be a potential holistic approach for treating multiorgan morbidity in MFS.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

添加到收藏夹

Article Genetics & Heredity

Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib-a case report

Yu-Feng Li, Xin-Fei Zhao, Yue Tian, Xin-Yao Xiao, Cai-Yun Yan, Hua Shen

Summary: Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of lung malignant tumor with suboptimal effectiveness with conventional chemotherapy. This case report demonstrates a patient with PSC complicating TP53 mutation who achieved clinical complete remission after treatment with Tislelizumab combined with Anlotinib, suggesting this combination therapy as a preferred strategy in such cases.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Respiratory System

Cardiopulmonary Exercise Testing in Combined Pulmonary Fibrosis and Emphysema

Michael Westhoff, Patric Litterst, Ralf Ewert

Summary: CPET can effectively differentiate CPFE patients with and without pulmonary hypertension by assessing parameters such as peak VO2, functional dead space ventilation, AaDO(2) at peak exercise, VE/VCO2 slope, and peak P(a-ET)CO2.CPET can noninvasively detect PH and identify high-risk patients by using a combination of parameters with high sensitivity and specificity.

RESPIRATION (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension

Kel Vin Woo, Isabel Y. Shen, Carla J. Weinheimer, Attila Kovacs, Jessica Nigro, Chieh-Yu Lin, Murali Chakinala, Derek E. Byers, David M. Ornitz

Summary: Research suggests that activation of endothelial FGFR signaling could be therapeutic for hypoxia-induced pulmonary hypertension by inhibiting the TGF-beta pathway-mediated EndMT process.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Review Immunology

Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review

Shugui Wu, Shanlian Wu, Xiaohong Liao, Chaoming Zhou, Feng Qiu, Chen Wang, Wenjuan Zhong

Summary: Combining pembrolizumab with anlotinib has shown significant therapeutic effects and improved quality of life in advanced PSC patients. Tumor mutation burden (TMB) and PD-L1 expression may serve as potential predictive biomarkers for immunotherapy efficacy in advanced PSC.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Genetics & Heredity

Case Report: A Deletion Variant in the DCAF17 Gene Underlying Woodhouse-Sakati Syndrome in a Chinese Consanguineous Family

Guangmin Chen, Ling Zhou, Qimou Chen, Juan Wang, Peng Jiang, Rufei Shen, Min Long, Houdi Zhou

Summary: Woodhouse-Sakati syndrome (WSS) is a rare neuroendocrine disease characterized by symptoms such as hair loss and hypogonadism. It is usually caused by mutations in the DCAF17 gene and often inherited in consanguineous families. This case report in China confirmed the diagnosis of WSS in a patient from a consanguineous family, with notable symptoms including alopecia and gonadal agenesis, along with hearing loss, intellectual disability, and hyperglycemia.

FRONTIERS IN GENETICS (2021)

添加到收藏夹

Article Critical Care Medicine

Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases

Jennifer Catano, Yurdagul Uzunhan, Romain Paule, Jeremie Dion, Alexis Regent, Paul Legendre, Francois Gonin, Emmanuel Martinod, Pascal Cohen, Xavier Puechal, Veronique Le Guern, Luc Mouthon, Andre Coste, Christine Lorut, Candice La Croix, Sophie Perie, Benjamin Terrier

Summary: This study found that GPA and RP are the two main inflammatory diseases presenting with SGS/TS. GPA-related stenoses are mostly subglottic and circumferential, whereas RP-related stenoses are mostly tracheal, anterior, and calcified with a frequent extension to bronchi.

CHEST (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

Vincent Cottin, Sonia Gueguen, Hilario Nunes, Stephane Jouneau, Bruno Crestani, Philippe Bonniaud, Lidwine Wemeau, Dominique Israel-Biet, Martine Reynaud-Gaubert, Anne Gondouin, Jacques Cadranel, Sylvain Marchand-Adam, Marie Chevereau, Isabelle Dufaure-Gare, Serge Amselem, Annick Clement

Summary: This study in France on IPF patients using pirfenidone capsules and tablets showed good acceptability of the tablet formulation among patients, suggesting possible advantages over the capsules. The study highlighted no new adverse events and lower discontinuation rates in the tablet and substitution subgroups compared to the capsules-only subgroup.

ADVANCES IN THERAPY (2022)

添加到收藏夹

Article Respiratory System

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study

Quentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, Clement Gauvain, Ibrahima Ba, Margherita Vieri, Anne Gondouin, Jean-Marc Naccache, Martine Reynaud-Gaubert, Yurdagul Uzunhan, Benjamin Bondue, Dominique Israel-Biet, Philippe Dieude, Cecile Fourrage, Elodie Lainey, Effrosyne Manali, Spyros Papiris, Lidwine Wemeau, Sandrine Hirschi, Herve Mal, Hilario Nunes, Frederic Schlemmer, Elodie Blanchard, Fabian Beier, Vincent Cottin, Bruno Crestani, Raphael Borie

Summary: This study describes the phenotype of patients with interstitial lung disease (ILD) and heterozygous PARN mutations, showing that idiopathic pulmonary fibrosis is common among individuals with PARN mutation. Other ILD subtypes may also be observed, and some patients may experience disease progression leading to death or lung transplantation despite specific treatment.

RESPIROLOGY (2022)

添加到收藏夹

Article Biophysics

Estimation of Regional Pulmonary Compliance in Idiopathic Pulmonary Fibrosis Based on Personalized Lung Poromechanical Modeling

Cecile Patte, Pierre-Yves Brillet, Catalin Fetita, Jean-Francois Bernaudin, Thomas Gille, Hilario Nunes, Dominique Chapelle, Martin Genet

Summary: Pulmonary function is closely related to lung mechanical behavior, and idiopathic pulmonary fibrosis (IPF) affects lung mechanics, thus altering lung function. Currently, the mechanical impact of IPF is only assessed through pressure-volume curves which provide global information. We have developed a personalized poromechanical model of the lung that can diagnose IPF based on clinical data.

JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME (2022)

添加到收藏夹

Article Respiratory System

French practical guidelines for the diagnosis and management of IPF-2021 update, short version

V Cottin, P. Bonniaud, J. Cadranel, B. Crestani, S. Jouneau, S. Marchand-Adam, H. Nunes, L. Wemeau-Stervinou, E. Bergot, E. Blanchard, R. Borie, A. Bourdin, C. Chenivesse, A. Clement, E. Gomez, A. Gondouin, S. Hirschi, F. Lebargy, C-H Marquette, D. Montani, G. Prevot, S. Quetant, M. Reynaud-Gaubert, M. Salaun, O. Sanchez, B. Trumbic, K. Berkani, P-Y Brillet, M. Campana, L. Chalabreysse, G. Chatte, D. Debieuvre, G. Ferretti, J-M Fourrier, N. Just, M. Kambouchner, B. Legrand, F. Le Guillou, J-P Lhuillier, A. Mehdaoui, J-M Naccache, C. Paganon, M. Remy-Jardin, S. Si-Mohamed, P. Terrioux

Summary: This study establishes practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis in clinical practice, based on evidence and the collaboration of experts in France.

REVUE DES MALADIES RESPIRATOIRES (2022)

添加到收藏夹

Article Rheumatology

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses

Paul Breillat, Kuberaka Mariampillai, Paul Legendre, Pauline Martins, Bertrand Dunogue, Jean Luc Charuel, Makoto Miyara, Claire Goulvestre, Romain Paule, Helene Vanquaethem, Felix Ackermann, Olivier Benveniste, Hilario Nunes, Luc Mouthon, Yves Allenbach, Yurdagul Uzunhan

Summary: This study identified three distinct clinical phenotypes and outcomes among patients with anti-PM-Scl-scleroderma antibodies positive autoimmune diseases. Skin thickening and non-specific interstitial pneumonia were crucial predictors in differentiating these subgroups.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Respiratory System

Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study

Frederic Schlemmer, Simon Valentin, Laurent Boyer, Anne Guillaumot, Francois Chabot, Clairelyne Dupin, Pierre Le Guen, Gwenael Lorillon, Anne Bergeron, Damien Basille, Julia Delomez, Claire Andrejak, Valentine Bonnefoy, Helene Goussault, Jean-Baptiste Assie, Pascaline Choinier, Anne-Marie Ruppert, Jacques Cadranel, Maria Chiara Mennitti, Mehdi Roumila, Charlotte Colin, Sven Gunther, Olivier Sanchez, Thomas Gille, Lucile Sese, Yurdagul Uzunhan, Morgane Faure, Maxime Patout, Capucine Morelot-Panzini, Pierantonio Laveneziana, Maeva Zysman, Elodie Blanchard, Chantal Raherison-Semjen, Violaine Giraud, Etienne Giroux-Leprieur, Stefanie Habib, Nicolas Roche, Anh Tuan Dinh-Xuan, Islem Sifaoui, Pierre-Yves Brillet, Camille Jung, Emmanuelle Boutin, Richard Layese, Florence Canoui-Poitrine, Bernard Maitre

Summary: This pragmatic study aimed to describe the clinical follow-up and respiratory recovery trajectories of survivors of severe-to-critical COVID-19, as well as identify factors influencing their health-related quality of life. The results showed that although pulmonary function and radiological abnormalities improved up to 1 year post-acute COVID-19, a high percentage of severe-to-critical disease survivors had significant lung sequelae and residual symptoms, warranting prolonged follow-up.

EUROPEAN RESPIRATORY JOURNAL (2023)

添加到收藏夹

Editorial Material Allergy

Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia

Quentin Delcros, Camille Taille, Alexandre Vallee, Anne-Laure Brun, Cecile Chenivesse, Priscille Couture, Selsabil Daboussi, Laurent Guilleminault, Fabienne Juster, Jean-Emmanuel Kahn, Guillaume Lefevre, Eric Liozon, Antoine Magnan, Sylvie Meireles, Guillaume Moulis, Corentin Puech, Colas Tcherakian, Julie Traclet, Yurdaguel Uzunhan, Vincent Cottin, Matthieu Groh

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

添加到收藏夹

Review Respiratory System

Lung transplantation for lymphangioleiomyomatosis

M. Reynaud-Gaubert, J. Le Pavec, Y. Uzunhan

REVUE DES MALADIES RESPIRATOIRES (2023)

添加到收藏夹

Article Genetics & Heredity

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, Adrian Gervais, Paul Bastard, Takaki Asano, Lucy Bizien, Federica Barzaghi, Hassan Abolhassani, Ahmad Abou Tayoun, Alessandro Aiuti, Ilad Alavi Darazam, Luis M. Allende, Rebeca Alonso-Arias, Andres Augusto Arias, Gokhan Aytekin, Peter Bergman, Simone Bondesan, Yenan T. Bryceson, Ingrid G. Bustos, Oscar Cabrera-Marante, Sheila Carcel, Paola Carrera, Giorgio Casari, Khalil Chaibi, Roger Colobran, Antonio Condino-Neto, Laura E. Covill, Ottavia M. Delmonte, Loubna El Zein, Carlos Flores, Peter K. Gregersen, Marta Gut, Filomeen Haerynck, Rabih Halwani, Selda Hancerli, Lennart Hammarstroem, Nevin Hatipoglu, Adem Karbuz, Sevgi Keles, Christele Kyheng, Rafael Leon-Lopez, Jose Luis Franco, Davood Mansouri, Javier Martinez-Picado, Ozge Metin Akcan, Isabelle Migeotte, Pierre-Emmanuel Morange, Guillaume Morelle, Andrea Martin-Nalda, Giuseppe Novelli, Antonio Novelli, Tayfun Ozcelik, Figen Palabiyik, Qiang Pan-Hammarstroem, Rebeca Perez de Diego, Laura Planas-Serra, Daniel E. Pleguezuelo, Carolina Prando, Aurora Pujol, Luis Felipe Reyes, Jacques G. Riviere, Carlos Rodriguez-Gallego, Julian Rojas, Patrizia Rovere-Querini, Agatha Schlueter, Mohammad Shahrooei, Ali Sobh, Pere Soler-Palacin, Yacine Tandjaoui-Lambiotte, Imran Tipu, Cristina Tresoldi, Jesus Troya, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Saleh Zaid Al-Muhsen, Mohammed Faraj Alosaimi, Fahad M. Alsohime, Hagit Baris-Feldman, Manish J. Butte, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Jacques Fellay, James R. Heath, Yu-Lung Lau, Richard P. Lifton, Tom Maniatis, Trine H. Mogensen, Horst von Bernuth, Alban Lermine, Michel Vidaud, Anne Boland, Jean-Francois Deleuze, Robert Nussbaum, Amanda Kahn-Kirby, France Mentre, Sarah Tubiana, Guy Gorochov, Florence Tubach, Pierre Hausfater, C. O. V. I. D. Human Genetic Effort, Isabelle Meyts, Shen-Ying Zhang, Anne Puel, Luigi D. Notarangelo, Stephanie Boisson-Dupuis, Helen C. Su, Bertrand Boisson, Emmanuelle Jouanguy, Jean-Laurent Casanova, Qian Zhang, Laurent Abel, Aurelie Cobat

Summary: Through a genome-wide rare variant burden association analysis, it was found that there is an association between at-risk variants in the TLR7 gene and rare loss-of-function variants in TLR3-dependent type I interferon immunity genes. These findings suggest that rare variants in TLR3- and TLR7-dependent type I interferon immunity genes may underlie life-threatening COVID-19 in patients under 60 years old.

GENOME MEDICINE (2023)

添加到收藏夹

Article Respiratory System

2022 Update of indications and contraindications for lung transplantation in France

Jerome Le Pavec, Christophe Pison, Sandrine Hirschi, Vincent Bunel, Pierre Mordant, Olivier Brugiere, Morgan Le Guen, Anne Olland, Benjamin Coiffard, Benjamin Renaud-Picard, Adrien Tissot, Geoffrey Brioude, Raphael Borie, Bruno Crestani, Gaetan Deslee, Sandrine Stelianides, Herve Mal, Armelle Schuller, Loic Falque, Gwenaelle Lorillon, Abdellatif Tazi, Pierre Regis Burgel, Dominique Grenet, Sandra De Miranda, Anne Bergeron, David Launay, Vincent Cottin, Hilario Nunes, Dominique Valeyre, Yurdagul Uzunhan, Gregoire Prevot, Olivier Sitbon, David Montani, Laurent Savale, Marc Humbert, Elie Fadel, Olaf Mercier, Jean Francois Mornex, Gaelle Dauriat, Martine Reynaud-Gaubert

Summary: Lung transplantation is a rapidly evolving field that has made significant advancements in improving donor and recipient selection, addressing surgical challenges, perioperative care, and long-term complications. To assist pulmonologists in managing end-stage respiratory insufficiency, determining eligibility for lung transplantation, and referring patients to transplant centers, the Francophone Pulmonology Society has established a task force to develop comprehensive guidelines based on the latest literature and evaluation of risk factors for patient survival after transplantation.

RESPIRATORY MEDICINE AND RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Systemic sclerosis associated interstitial lung disease: a survey of current practices in France

Amelie Nicolas, Sylvie Leroy, Luc Mouthon, Yurdagul Uzunhan, Vincent Cottin, Arsene Mekinian, Viviane Queyrel, Eric Hachulla, Benoit Gachet, David Launay, Nihal Martis

Summary: This study provides an overview of the diagnostic approaches, follow-up, and treatment strategies used in France for the management of SSc-associated ILD. The results highlight the heterogeneity and gaps in current clinical practices, calling for improvement and standardization.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

添加到收藏夹

Letter Critical Care Medicine

Authors' reply

Jean-Marc Naccache, Marine Cachanado, Alexandra Rousseau, Hilario Nunes

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Respiratory System

ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly

Sabina A. Guler, Sara Cuevas-Ocana, Mouhamad Nasser, Wim A. Wuyts, Marlies S. Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A. Renzoni, Marcel Veltkamp, Paolo Spagnolo, Hilario Nunes, Cormac McCarthy, Maria Molina-Molina, Francesco Bonella, Venerino Poletti, Michael Kreuter, Katerina M. Antoniou, Catharina C. Moor

Summary: This article provides an overview of scientific highlights in the field of interstitial lung disease (ILD) presented at the virtual European Respiratory Society Congress 2021, covering a wide range of topics from translational and genetic aspects to potential innovations in patient care. Early Career Members and the leadership of Assembly 12 - Interstitial Lung Disease summarize selected interesting findings from various congress sessions.

ERJ OPEN RESEARCH (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.